OmniaBio: Bringing Maturity to Cell and Gene Therapy (Drone Video)

At 120,000 square feet, and visible from the highway that passes alongside McMaster Innovation Park in Hamilton, Ontario, OmniaBio Inc. is a beacon for cell and gene therapy companies.

A subsidiary of CCRM, OmniaBio is built on a strong foundation established more than a decade ago. With the singular purpose of optimizing and manufacturing cells and viral vectors, OmniaBio is bringing maturity to the industry: it will be Canada’s largest contract manufacturer dedicated to cell and gene therapies.

Learn more about OmniaBio at www.omniabio.com.

MaRS Centre, West Tower
661 University Avenue, Suite 1002
Toronto, Ontario M5G 1M1 Canada
t: 416-978-3751
f: 416-978-1368

We wish to acknowledge this land on which CCRM operates. For thousands of years, it has been the traditional land of the Huron-Wendat, the Seneca, and the Mississaugas of the Credit. Today, this meeting place is still the home to many Indigenous people from across Turtle Island and we are grateful to have the opportunity to work on this land.